Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

An analysis of the economic impact of smoking cessation in Europe

Authors: David Cohen, M Fasihul Alam, Paul S Jarvis

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

There is much evidence that smoking cessation interventions are both clinically and cost effective but these results relate only to the specific study populations involved in the studies. The present study aimed to compare and contrast results obtained when the effects of smoking cessation are modelled for several different European countries.

Methods

Local investigators collected data relating to several smoking related diseases. Costs and disease rates were then modelled up to 2030 for reductions in smoking of 3%, 15% and 30% using an epidemiological modelling tool, PREVENT.

Results

Models could not be constructed for some countries due to lack of data while for others substantial amounts of data had to be imputed. In all cases, disease rates fall when smoking cessation occurs. Overall costs initially fall before eventually rising as lives are saved and the population ages, leading to negative savings in some cases by the end of the modelled period. The speed and magnitude with which these effects occur are diverse for different countries.

Conclusions

Health and economic results for different countries vary significantly for the same reductions in smoking. This suggests that it may be inappropriate to assume that evidence from one country will produce similar health and economic effects if the same levels of smoking cessation were achieved in another country which has evident messages for health policy. Problems with obtaining data also highlight the difficulties associated with modelling such scenarios and underline the need for relevant data to be routinely collected in all countries.
Appendix
Available only for authorised users
Literature
1.
go back to reference Evidence Based Medicine Working Group: Evidence based medicine: a new approach to teaching the practice of medicine. J Am Med Assoc. 1992, 268: 242-245. Evidence Based Medicine Working Group: Evidence based medicine: a new approach to teaching the practice of medicine. J Am Med Assoc. 1992, 268: 242-245.
2.
go back to reference National Institute for Clinical Excellence: Guide to the methods of technology appraisal. 2004, London: National Institute for Clinical Excellence National Institute for Clinical Excellence: Guide to the methods of technology appraisal. 2004, London: National Institute for Clinical Excellence
3.
go back to reference Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N: Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Medical Decision Making. 2002, 22 (Supplement): S26-S37.CrossRefPubMed Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N: Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Medical Decision Making. 2002, 22 (Supplement): S26-S37.CrossRefPubMed
4.
go back to reference Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Molken MP: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health. 2005, 8 (3): 178-190. 10.1111/j.1524-4733.2005.04008.x.CrossRefPubMed Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Molken MP: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health. 2005, 8 (3): 178-190. 10.1111/j.1524-4733.2005.04008.x.CrossRefPubMed
5.
go back to reference Godfrey C, Parrott S, Coleman T, Pound E: The cost-effectiveness of the English smoking treatment services: evidence from practice. Addiction. 2005, 100 (Suppl 2): 70-83.CrossRefPubMed Godfrey C, Parrott S, Coleman T, Pound E: The cost-effectiveness of the English smoking treatment services: evidence from practice. Addiction. 2005, 100 (Suppl 2): 70-83.CrossRefPubMed
7.
go back to reference Gunning-Schepers L: The health benefits of prevention: a simulation approach. Health Policy. 1989, 12 (1–2): 1-255.PubMed Gunning-Schepers L: The health benefits of prevention: a simulation approach. Health Policy. 1989, 12 (1–2): 1-255.PubMed
9.
10.
go back to reference Britton M: The burden of COPD in the UK: results from the confronting COPD survey. Respir Med. 2003, 97 (Sup C): S71-S79.CrossRefPubMed Britton M: The burden of COPD in the UK: results from the confronting COPD survey. Respir Med. 2003, 97 (Sup C): S71-S79.CrossRefPubMed
11.
go back to reference Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M: Cost of Cardiovascular disease in the United Kingdom. Heart. 2006, 92: 1384-1389. 10.1136/hrt.2005.072173.CrossRefPubMedPubMedCentral Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M: Cost of Cardiovascular disease in the United Kingdom. Heart. 2006, 92: 1384-1389. 10.1136/hrt.2005.072173.CrossRefPubMedPubMedCentral
12.
go back to reference Select Committee on Health: Minutes of Evidence. House of Commons. 2000, London: The Stationary Office Select Committee on Health: Minutes of Evidence. House of Commons. 2000, London: The Stationary Office
13.
go back to reference Wilson D, Adams R, Appleton S, Ruffin R: Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD. Chest. 2005, 128: 2035-2042. 10.1378/chest.128.4.2035.CrossRefPubMed Wilson D, Adams R, Appleton S, Ruffin R: Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD. Chest. 2005, 128: 2035-2042. 10.1378/chest.128.4.2035.CrossRefPubMed
14.
go back to reference Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. Br Med J. 1989, 298: 789-794. 10.1136/bmj.298.6676.789.CrossRef Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. Br Med J. 1989, 298: 789-794. 10.1136/bmj.298.6676.789.CrossRef
17.
go back to reference Bertera RL: The effects of behavioural risks on absenteeism and health care costs in the workplace. J Occup Med. 1991, 33: 119-124.CrossRef Bertera RL: The effects of behavioural risks on absenteeism and health care costs in the workplace. J Occup Med. 1991, 33: 119-124.CrossRef
18.
go back to reference Townsend J: Cost effectiveness and mass media programmes of smoking control. Smoking control: strategies and evaluation in community and mass media programmes. Edited by: Crofton J, Wood M. 1986, London: Health Education Council, & Belfast: The Ulster Cancer Foundation, & Edinburgh: Scottish Health Education Group Townsend J: Cost effectiveness and mass media programmes of smoking control. Smoking control: strategies and evaluation in community and mass media programmes. Edited by: Crofton J, Wood M. 1986, London: Health Education Council, & Belfast: The Ulster Cancer Foundation, & Edinburgh: Scottish Health Education Group
20.
go back to reference Nelson H: The Economic Consequences of Smoking in Northern Ireland. 1986, Belfast: Ulster Cancer Foundation Nelson H: The Economic Consequences of Smoking in Northern Ireland. 1986, Belfast: Ulster Cancer Foundation
Metadata
Title
An analysis of the economic impact of smoking cessation in Europe
Authors
David Cohen
M Fasihul Alam
Paul S Jarvis
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-390

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue